TPD3310
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TPD3310, covering 2026-01-26 to 2026-01-26. Get the full timeline:
Most recent: Clinical Trial Update: A Study of TPD3310 in Patients With Advanced Malignant Tumors [Phase 1]